Theraclion SA (EPA:ALTHE)
France · Delayed Price · Currency is EUR 0.5860
+0.0050 (0.86%)
Aug 3, 2026, 12:56 PM CET
Theraclion Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.38 | 4.17 | 7.82 | 2.49 | 2.46 |
Short-Term Investments | - | - | - | 0.03 | 0.03 |
Cash & Short-Term Investments | 3.38 | 4.17 | 7.82 | 2.52 | 2.49 |
Cash Growth | -18.99% | -46.63% | 210.14% | 1.10% | 6.29% |
Accounts Receivable | 0.75 | 0.36 | 3.18 | 2.29 | 1.36 |
Other Receivables | 2.49 | 1.62 | 1.95 | 1.47 | 1.41 |
Total Trade Receivables | 3.24 | 1.98 | 5.13 | 3.76 | 2.77 |
Inventory | 2.57 | 2.11 | 3.05 | 3.06 | 2.64 |
Other Current Assets | 0.11 | 0.01 | 0.11 | 0.01 | 0.03 |
Total Current Assets | 9.3 | 8.27 | 16.11 | 9.35 | 7.94 |
Net Property, Plant & Equipment | 0.88 | 0.86 | 0.11 | 0.13 | 0.05 |
Other Intangible Assets | 1.13 | 1.13 | 1.23 | 1.3 | 0.96 |
Long-Term Investments | 1.01 | 1.02 | 1.02 | 2.93 | 2.83 |
Other Long-Term Assets | 0.19 | 0.18 | 0.2 | 0.24 | 0.06 |
Total Assets | 12.51 | 11.47 | 18.66 | 13.94 | 11.83 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.39 | 1.44 | 1.98 | 1.73 | 0.98 |
Accrued Expenses | 1.27 | 1.19 | 1.41 | 1.68 | 1.85 |
Current Portion of Long-Term Debt | 5.09 | 1.3 | 8.46 | 9.34 | 9.41 |
Unearned Revenue | 0.61 | 0.72 | 1.05 | 0.79 | 0.6 |
Other Current Liabilities | 0.46 | 0.65 | 0.55 | 0.17 | 0.22 |
Total Current Liabilities | 8.79 | 5.04 | 13.45 | 13.71 | 13.06 |
Other Long-Term Liabilities | 12.58 | 12.58 | 12.58 | 13.07 | 13.09 |
Total Long-Term Liabilities | 12.58 | 12.58 | 12.58 | 13.07 | 13.09 |
Total Liabilities | 21.37 | 17.62 | 26.03 | 26.79 | 26.15 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.99 | 2.32 | 2.29 | 1.47 | 1.14 |
Additional Paid-in Capital | 2.43 | 3.44 | 7.96 | 4.04 | 1.35 |
Retained Earnings | -8.01 | -5.76 | -2.75 | -4.96 | -3.76 |
Shareholders' Equity | -2.59 | 0 | 5.65 | 0.54 | -1.27 |
Total Liabilities & Equity | 12.51 | 11.47 | 18.66 | 13.94 | 11.83 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5.09 | 1.3 | 8.46 | 9.34 | 9.41 |
Net Cash (Debt) | -1.71 | 2.88 | -0.64 | -6.82 | -6.92 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.03 | 0.06 | -0.01 | -0.21 | -0.30 |
Book Value | -2.59 | 0 | 5.65 | 0.54 | -1.27 |
Book Value Per Share | -0.05 | - | 0.12 | 0.02 | -0.06 |
Tangible Book Value | -3.72 | -1.13 | 4.42 | -0.75 | -2.23 |
Tangible Book Value Per Share | -0.07 | -0.02 | 0.09 | -0.02 | -0.10 |